Your browser doesn't support javascript.
loading
m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance.
Zhou, Tengfei; Li, Shichao; Xiang, Daimin; Liu, Junyu; Sun, Wen; Cui, Xiuliang; Ning, Beifang; Li, Xiao; Cheng, Zhuo; Jiang, Weiqi; Zhang, Cheng; Liang, Xijun; Li, Liang; Cheng, Xin; Hui, Liu; Wang, Hongyang; Ding, Jin.
Afiliação
  • Zhou T; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Li S; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Xiang D; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Liu J; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Sun W; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Cui X; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Ning B; Department of Gastroenterology, Changzheng Hospital, The Second Military Medical University, Shanghai, China.
  • Li X; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Cheng Z; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Jiang W; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Zhang C; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Liang X; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Li L; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China.
  • Cheng X; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
  • Hui L; The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, China. liuhuigg@hotmail.com.
  • Wang H; International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital/Institute, The Second Military Medical University, Shanghai, China. hywangk@vip.sina.com.
  • Ding J; National Center for Liver Cancer, Shanghai, China. hywangk@vip.sina.com.
Signal Transduct Target Ther ; 5(1): 296, 2020 12 26.
Article em En | MEDLINE | ID: mdl-33361765
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Mensageiro / RNA Neoplásico / Processamento Pós-Transcricional do RNA / Carcinoma Hepatocelular / Resistencia a Medicamentos Antineoplásicos / Fator 3-gama Nuclear de Hepatócito / Desdiferenciação Celular / Sorafenibe / Neoplasias Hepáticas / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA Mensageiro / RNA Neoplásico / Processamento Pós-Transcricional do RNA / Carcinoma Hepatocelular / Resistencia a Medicamentos Antineoplásicos / Fator 3-gama Nuclear de Hepatócito / Desdiferenciação Celular / Sorafenibe / Neoplasias Hepáticas / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido